Mitotic and antiapoptotic effects of nanoparticles coencapsulating human VEGF and human angiopoietin-1 on vascular endothelial cells

References

• HolashJWiegandSJYancopoulosGDNew model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGFOncogene199918385356536210498889
   PubMed Web of Science ®Google Scholar
• IsnerJMAsaharaTAngiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularizationJ Clin Invest199910391231123610225965
   PubMed Web of Science ®Google Scholar
• KerrJFWyllieAHCurrieARApoptosis: A basic biological phenomenon with wide-ranging implications in tissue kineticsBr J Cancer19722642392574561027
   PubMed Web of Science ®Google Scholar
• FujioYWalshKAkt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent mannerJ Biol Chem199927423163491635410347193
   PubMed Web of Science ®Google Scholar
• GerberHPDixitVFerraraNVascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cellsJ Biol Chem19982732113313133169582377
   PubMed Web of Science ®Google Scholar
• GerberHPMcMurtreyAKowalskiJVascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3’-kinase Akt signal transduction pathway – requirement for Flk-1/KDR activationJ Biol Chem19982734630336303439804796
   PubMed Web of Science ®Google Scholar
• AsaharaTBautersCZhengLPSynergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivoCirculation1995929 SupplII365II3717586439
   PubMed Web of Science ®Google Scholar
• BanaiSJaklitschMTShouMAngiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogsCirculation1994895218321897514110
   PubMed Web of Science ®Google Scholar
• BautersCAsaharaTZhengLPPhysiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimbAm J Physiol19942674 Pt 2H1263HI12717943370
   PubMedGoogle Scholar
• BautersCAsaharaTZhengLPSite-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factorJ Vasc Surg19952123143247531786
   PubMed Web of Science ®Google Scholar
• BautersCAsaharaTZhengLPRecovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factorCirculation19959111280228097758187
   PubMed Web of Science ®Google Scholar
• TakeshitaSPuLQSteinLAIntramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemiaCirculation1994905 Pt 2II228II2347525111
   PubMed Web of Science ®Google Scholar
• TakeshitaSRossowSTKearneyMTime course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiencyAm J Pathol19951476164916607495290
   PubMed Web of Science ®Google Scholar
• TakeshitaSZhengLPBrogiETherapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb modelJ Clin Invest19949326626707509344
   PubMed Web of Science ®Google Scholar
• BatesDOHarperSJRegulation of vascular permeability by vascular endothelial growth factorsVascul Pharmacol2002394–522523712747962
   PubMed Web of Science ®Google Scholar
• DvorakHFNagyJAFengDBrownLFDvorakAMVascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesisCurr Top Microbiol Immunol1999237971329893348
   PubMed Web of Science ®Google Scholar
• LeeRJSpringerMLBlanco-BoseWEShawRUrsellPCBlauHMVEGF gene delivery to myocardium: Deleterious effects of unregulated expressionCirculation2000102889890110952959
   PubMed Web of Science ®Google Scholar
• GambleJRDrewJTreziseLAngiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctionsCirc Res200087760360711009566
   PubMed Web of Science ®Google Scholar
• ThurstonGRudgeJSIoffeEAngiopoietin-1 protects the adult vasculature against plasma leakageNat Med20006446046310742156
   PubMed Web of Science ®Google Scholar
• ThurstonGSuriCSmithKLeakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1Science199928654492511251410617467
   PubMed Web of Science ®Google Scholar
• KimIKimHGSoJNKimJHKwakHJKohGYAngiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3’-Kinase/Akt signal transduction pathwayCirc Res2000861242910625301
   PubMed Web of Science ®Google Scholar
• KwakHJSoJNLeeSJKimIKohGYAngiopoietin-1 is an apoptosis survival factor for endothelial cellsFEBS Lett19994482–324925310218485
   PubMed Web of Science ®Google Scholar
• KandaSMiyataYMochizukiYMatsuyamaTKanetakeHAngiopoietin 1 is mitogenic for cultured endothelial cellsCancer Res200565156820682716061664
   PubMed Web of Science ®Google Scholar
• HayesAJHuangWQMallahJYangDLippmanMELiLYAngiopoietin-1 and its receptor Tie-2 participate in the regulation of capillarylike tubule formation and survival of endothelial cellsMicrovasc Res199958322423710527766
   PubMed Web of Science ®Google Scholar
• KoblizekTIWeissCYancopoulosGDDeutschURisauWAngiopoietin-1 induces sprouting angiogenesis in vitroCurr Biol1998895295329560344
   PubMed Web of Science ®Google Scholar
• CaoRBrakenhielmEPawliukRAngiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2Nat Med20039560461312669032
   PubMed Web of Science ®Google Scholar
• RichardsonTPPetersMCEnnettABMooneyDJPolymeric system for dual growth factor deliveryNat Biotechnol200119111029103411689847
   PubMed Web of Science ®Google Scholar
• SaifJSchwarzTMChauDYCombination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularizationArterioscler Thromb Vasc Biol201030101897190420689075
   PubMed Web of Science ®Google Scholar
• RavivarapuHBBurtonKDeLucaPPPolymer and microsphere blending to alter the release of a peptide from PLGA microspheresEur J Pharm Biopharm200050226327010962237
   PubMed Web of Science ®Google Scholar
• SandersLMDrug delivery systems and routes of administration of peptide and protein drugsEur J Drug Metab Pharmacokinet1990152951022200689
   PubMed Web of Science ®Google Scholar
• KingTWPatrickCWJrDevelopment and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction techniqueJ Biomed Mater Res200051338339010880080
   PubMed Web of Science ®Google Scholar
• PanyamJLabhasetwarVBiodegradable nanoparticles for drug and gene delivery to cells and tissueAdv Drug Deliv Rev200355332934712628320
   PubMed Web of Science ®Google Scholar
• Kragh-HansenUStructure and ligand binding properties of human serum albuminDan Med Bull199037157842155760
   PubMed Web of Science ®Google Scholar
• Kragh-HansenUChuangVTOtagiriMPractical aspects of the ligandbinding and enzymatic properties of human serum albuminBiol Pharm Bull200225669570412081132
   PubMed Web of Science ®Google Scholar
• GalloGRWertheimerAIAn international survey of drug information centersDrug Inf J1985191576110270137
   PubMedGoogle Scholar
• LinWCoombesAGDaviesMCDavisSSIllumLPreparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation methodJ Drug Target1993132372438069565
   PubMed Web of Science ®Google Scholar
• WeberCKreuterJLangerKDesolvation process and surface characteristics of HSA-nanoparticlesInt J Pharm2000196219720010699717
   PubMed Web of Science ®Google Scholar
• MoYBarnettMETakemotoDDavidsonHKompellaUBHuman serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase geneMol Vis20071374675717563725
   PubMed Web of Science ®Google Scholar
• SebakSMirzaeiMMalhotraMKulamarvaAPrakashSHuman serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: Preparation and in vitro analysisInt J Nanomedicine2010552553220957217
   PubMed Web of Science ®Google Scholar
• AdyaRTanBKPunnAChenJRandevaHSVisfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: Novel insights into visfatin-induced angiogenesisCardiovasc Res200878235636518093986
   PubMed Web of Science ®Google Scholar
• AfkhamiFDurocherYPrakashSInvestigation of antiangiogenic tumor therapy potential of microencapsulated HEK293 VEGF165b producing cellsJ Biomed Biotechnol2010201064561020976076
   PubMedGoogle Scholar
• Milovic-HolmKKrieghoffEJensenKWillHHofmannTGFLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodiesEMBO J200726239140117245429
   PubMed Web of Science ®Google Scholar
• LinWCoombesAGGarnettMCPreparation of sterically stabilized human serum albumin nanospheres using a novel Dextranox-MPEG crosslinking agentPharm Res19941111158815927532861
   PubMed Web of Science ®Google Scholar
• ZhangSWangGLinXPolyethylenimine-coated albumin nanoparticles for BMP-2 deliveryBiotechnol Prog200824494595619194903
   PubMed Web of Science ®Google Scholar